Bugworks Research Inc.

This early-stage study tests the safety and how the body handles a new antibiotic called BWC0977. It involves 48 healthy adults aged 18 to 55 who will receive either the drug or a placebo by IV. The goal is to find safe doses for future studies targeting drug-resistant bacterial …